Back to
SC US (TTGP), LTD.
BBIO29 quarters
Position history for
SC US (TTGP), LTD.'s holdings in BRIDGEBIO PHARMA INC
Yes. SC US (TTGP) holds 1,860,364 shares of BBIO (Bridgebio Pharma), worth $138.6M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. SC US (TTGP) has held BBIO since Q2 2019, across 29 quarterly 13F filings. BBIO is 0.4% of SC US (TTGP)'s reported 13F portfolio.
Current Value
$138.6M
Current Shares
1.9M
Total Value Change
+$69.9M
Total Shares Change
-684,374
Quarter-by-Quarter History
Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC